DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Upgraded by Bank of America

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by Bank of America from a “neutral” rating to a “buy” rating in a research note issued on Thursday, Marketbeat Ratings reports. The brokerage presently has a $17.00 price target on the medical instruments supplier’s stock, up from their prior price target of $13.00. Bank of America‘s price target points to a potential upside of 36.11% from the stock’s previous close.

Other research analysts also recently issued reports about the company. Barclays initiated coverage on DENTSPLY SIRONA in a research report on Monday, December 8th. They issued an “underweight” rating and a $12.00 price target on the stock. Stifel Nicolaus set a $13.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, November 6th. Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, November 7th. UBS Group decreased their price target on shares of DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating on the stock in a research report on Tuesday, February 3rd. Finally, Zacks Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Three research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $14.46.

DENTSPLY SIRONA Stock Up 0.4%

XRAY stock opened at $12.49 on Thursday. The stock has a market capitalization of $2.49 billion, a price-to-earnings ratio of -2.83, a price-to-earnings-growth ratio of 0.98 and a beta of 1.01. The company has a 50-day moving average of $12.20 and a two-hundred day moving average of $12.50. DENTSPLY SIRONA has a 52-week low of $9.85 and a 52-week high of $19.27. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of the firm’s stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Eurizon Capital SGR S.p.A. bought a new position in DENTSPLY SIRONA in the 4th quarter valued at $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of DENTSPLY SIRONA during the first quarter worth $26,000. Parkside Financial Bank & Trust lifted its stake in shares of DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,477 shares during the period. Huntington National Bank boosted its holdings in DENTSPLY SIRONA by 292.9% in the third quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,077 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its position in DENTSPLY SIRONA by 337.9% in the third quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 2,122 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.